TTNP Market Cap History
Below is a table of the TTNP market cap history going back to 9/29/2015:

Date TTNP Market Cap
9/29/201580.64M
10/12/201592.08M
11/10/201584.25M
3/10/201671.21M
5/6/2016102.03M
8/5/2016107.27M
11/4/201695.39M
3/10/201777.38M
5/5/201758.31M
8/4/201740.29M
11/3/201741.35M
3/23/201823.75M
5/9/201814.63M
8/10/201819.72M
11/9/201831.19M
1/25/201918.84M
3/25/201923.88M
5/10/201922.83M
8/9/201911.96M
11/11/20199.44M
3/25/202024.30M
5/12/202033.48M
8/10/202030.14M
11/10/202027.55M
12/1/202024.66M
3/26/202127.62M

Also see: TTNP Shares Outstanding History
and TTNP YTD Return
TTNP Historical Market Cap:
-17.72% CAGR
TTNP Historical Market Cap: +-17.72% CAGR

Mouse over chart for data details
9/29/2015 ...3/26/2021
Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura™, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis. We show 26 historical shares outstanding datapoints in our TTNP shares outstanding history coverage, used to compute TTNP market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing TTNP market cap history over the course of time is important for investors interested in comparing TTNP's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of TTNP versus a peer is one thing; comparing TTNP market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like TTNP can fluctuate over the course of history. With this page we aim to empower investors researching TTNP by allowing them to research the TTNP market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for TTNP:
TTNP SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Titan Pharmaceuticals (TTNP) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

TTOO Market Cap History
TTPH Market Cap History
TVTY Market Cap History
TXMD Market Cap History
TYME Market Cap History
UHS Market Cap History
USPH Market Cap History
UTHR Market Cap History
UTMD Market Cap History
VAR Market Cap History
More Healthcare companies »

 

TTNP Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.